Want to track SNW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
SNW trading today higher at zł1.51, an increase of 1.0033% from yesterday's close, completing a monthly increase of 3.4247% or zł0.05. Over the past 12 months, SNW stock gained 16.1538%.
SNW is not paying dividends to its shareholders.
The last earnings report, released on Dec 31, 2016, exceeded the consensus estimates by 0.1143%. On average, the company has surpassed earnings expectations by 0.0159%, based on the last three reports.
Sanwil Holding S.A. has completed 4 stock splits, with the recent split occurring on Mar 26, 2015.
The company's stock is traded on 12 different exchanges and in various currencies, with the primary listing on LSE (EUR).
SNW Chart
Sanwil Holding S.A. (SNW) FAQ
What is the stock price today?
The current price is zł1.51.
On which exchange is it traded?
Sanwil Holding S.A. is listed on WSE.
What is its stock symbol?
The ticker symbol is SNW.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 15.68%.
What is its market cap?
As of today, no market cap data is available.
Has Sanwil Holding S.A. ever had a stock split?
Sanwil Holding S.A. had 4 splits and the recent split was on Mar 26, 2015.
Sanwil Holding S.A. Profile
| Pharmaceuticals Industry | Healthcare Sector | Mr. Adam Buchajski CEO | WSE Exchange | PLSANWL00012 ISIN |
| Poland Country | 88 Employees | 5 May 2026 Last Dividend | - Last Split | - IPO Date |
Sanofi SA is a French multinational pharmaceutical and healthcare company headquartered in Paris, renowned for its research, development, manufacturing, and marketing of innovative medicines and vaccines. Established in 1973, it has evolved through key mergers, including with Synthélabo in 1999 and Aventis in 2004, forming a global leader with over 90,000 employees across 90 countries. Sanofi focuses on seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines, positioning it as the world's largest vaccine producer via its Sanofi Pasteur subsidiary. Its portfolio spans prescription drugs like Dupixent for eczema and autoimmune conditions, Lovenox for thrombosis, Taxotere for cancer, and treatments for rare diseases such as Gaucher's and hemophilia. Sanofi also offers over-the-counter products including Allegra and IcyHot. As an R&D-driven, AI-powered biopharma entity, it invests heavily in immunology, neurology, diabetes innovation, and mRNA technologies, maintaining a robust pipeline of 80 compounds in clinical development across five therapeutic areas to address unmet medical needs and advance public health worldwide.
Contact Information
Address: ul. Cisowa 11
Phone: 48 81 444 6480
Website: https://www.holding.sanwil.com
